EUVIMEDEUVIMED entdecken
Crossref

Novel pathophysiological functions of Na+,K+-ATPases and Cl− channels in cancer cells

Takuto Fujii, Takahiro Shimizu, Hideki Sakai

Folia Pharmacologica Japonica · 2023

DOI: 10.1254/fpj.23057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Folia Pharmacologica Japonica, 2023. Verfasst von Takuto Fujii und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, University of Toyama. Hauptthemen laut MEDLINE: Cardiac Glycosides, Neoplasms. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Na+,K+-ATPases are essential for maintaining the membrane potential in almost all cells, and their catalytic subunits have four isoforms (α1-α4). Volume-regulated anion channel (VRAC) plays an important role in the cell death signaling pathway in addition to its fundamental role in cell volume maintenance. First, we introduce that disruption of actin filaments cause the dysfunction of VRAC, which elicits resistance to cisplatin in the cancer cells. Next, we summarize the cardiac glycosides-induced signaling pathway mediated by the crosstalk between Na+,K+-ATPase α1-isoform (α1NaK) and VRAC in the membrane microdomain of the cancer cells. In this mechanism, sub-micromolar concentrations of cardiac glycosides bind to the receptor-type α1NaK, and generate VRAC activities concomitantly with a deceleration of cancer cell proliferation. Finally, we summarize the pathophysiological function of α3NaK, which is abnormally expressed in the intracellular vesicles of cancer cells. The cancer cell can survive even under loss of anchorage because they have the avoidance mechanism for anoikis. On cancer cell detachment, we found that intracellular α3NaK is translocated to the plasma membrane and this event contributes to the survival of the cells. Interestingly, cardiac glycosides inhibited the α3NaK translocation and cell survival. Our findings may open up new opportunities for the development of cancer medicines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac GlycosidesNeoplasmsHumansSodium-Potassium-Exchanging ATPaseCell MembraneIonsSignal Transduction

Substanzen

Sodium-Potassium-Exchanging ATPaseCardiac GlycosidesIons

Autor:innen und Institutionen

  • Faculty of Pharmaceutical Sciences, University of Toyama.

Zitieren

APA

Fujii, T., Shimizu, T., & Sakai, H. (2023). Novel pathophysiological functions of Na+,K+-ATPases and Cl− channels in cancer cells. Folia Pharmacologica Japonica. https://doi.org/10.1254/fpj.23057

Vancouver

Fujii T, Shimizu T, Sakai H. Novel pathophysiological functions of Na+,K+-ATPases and Cl− channels in cancer cells. Folia Pharmacologica Japonica. 2023. doi:10.1254/fpj.23057

BibTeX
@article{Fujii2023,
  author = {Fujii, Takuto and Shimizu, Takahiro and Sakai, Hideki},
  title = {Novel pathophysiological functions of Na+,K+-ATPases and Cl− channels in cancer cells},
  journal = {Folia Pharmacologica Japonica},
  year = {2023},
  doi = {10.1254/fpj.23057}
}
Kostenlos starten →